{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:57:40Z","timestamp":1756897060393,"version":"3.37.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Western and South-Eastern Regional Health Authorities of Norway"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Statin treatment has been associated with reduction in blood pressure and arterial stiffness in patients with inflammatory joint diseases (IJD). We tested whether statin treatment also was associated with regression of preclinical cardiac organ damage in IJD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Echocardiography was performed in 84 IJD patients (52 RA, 20 ankylosing spondylitis, 12 psoriatric arthritis, mean age 61\u2009(9) years, 63% women) without known cardiovascular disease before and after 18\u2009months of rosuvastatin treatment. Preclinical cardiac organ damage was identified by echocardiography as presence of left ventricular (LV) hypertrophy, LV concentric geometry, increased LV chamber size and\/or dilated left atrium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At baseline, hypertension was present in 63%, and 36% used biologic DMARDs (bDMARDs). Preclinical cardiac organ damage was not influenced by rosuvastatin treatment (44% at baseline vs 50% at follow-up, P\u2009=\u20090.42). In uni- and multivariable logistic regression analyses, risk of preclinical cardiac organ damage at follow-up was increased by higher baseline body mass index [odds ratio (OR) 1.3, 95% CI: 1.1, 1.5, P\u2009=\u20090.01] and presence of preclinical cardiac organ damage at baseline (OR 6.4, 95% CI: 2.2, 18.5, P\u2009=\u20090.001) and reduced by use of bDMARDs at follow-up (OR 0.3, 95% CI: 0.1, 0.9, P\u2009=\u20090.03).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Rosuvastatin treatment was not associated with a reduction in preclinical cardiac organ damage in IJD patients after 18\u2009months of treatment. However, use of bDMARDS at follow-up was associated with lower risk of preclinical cardiac organ damage at study end, pointing to a possible protective cardiac effect of bDMARDs in IJD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>ClinicalTrials.gov<\/jats:title>\n                  <jats:p>https:\/\/clinicaltrials.gov\/NCT01389388<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa190","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T03:30:35Z","timestamp":1585625435000},"page":"3700-3708","source":"Crossref","is-referenced-by-count":4,"title":["Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study"],"prefix":"10.1093","volume":"59","author":[{"given":"Hanna A","family":"Os","sequence":"first","affiliation":[{"name":"Department of Clinical Science, University of Bergen, Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rollefstad","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gerdts","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen, Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Kringeland","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen, Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"Ikdahl","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Grete","family":"Semb","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Midtb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2021031104123908400_keaa190-B1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","article-title":"Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis","volume":"76","author":"Schieir","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021031104123908400_keaa190-B2","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021031104123908400_keaa190-B3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez409","article-title":"Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study","volume":"59","author":"Nikiphorou","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2021031104123908400_keaa190-B4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2021031104123908400_keaa190-B5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ejechocard\/jen155","article-title":"Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)","volume":"9","author":"Gerdts","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2021031104123908400_keaa190-B6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/acr.23765","article-title":"Left ventricular systolic myocardial function in ankylosing spondylitis","volume":"71","author":"Midtb\u00f8","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021031104123908400_keaa190-B7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/annrheumdis-2016-209223","article-title":"Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis","volume":"76","author":"Midtb\u00f8","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021031104123908400_keaa190-B8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/rheumatology\/keu368","article-title":"Disease activity and left ventricular structure in patients with rheumatoid arthritis","volume":"54","author":"Midtb\u00f8","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2021031104123908400_keaa190-B9","doi-asserted-by":"crossref","first-page":"e000144","DOI":"10.1161\/JAHA.113.000144","article-title":"Lack of reduction of left ventricular mass in treated hypertension: the strong heart study","volume":"2","author":"de Simone","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2021031104123908400_keaa190-B10","doi-asserted-by":"crossref","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network)","volume":"6","author":"L\u00f8nnebakken","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021031104123908400_keaa190-B11","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1253\/circj.CJ-12-0722","article-title":"Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years\u2019 follow-up","volume":"76","author":"Warita","year":"2012","journal-title":"Circ J"},{"key":"2021031104123908400_keaa190-B12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","article-title":"Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure","volume":"47","author":"Sola","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2021031104123908400_keaa190-B13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2362.2007.01877.x","article-title":"HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study","volume":"37","author":"Bauersachs","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"2021031104123908400_keaa190-B14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/pds.4389","article-title":"New statin use and left ventricular structure: estimating long-term associations in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"27","author":"Strand","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021031104123908400_keaa190-B15","doi-asserted-by":"crossref","first-page":"e0153440","DOI":"10.1371\/journal.pone.0153440","article-title":"Sustained improvement of arterial stiffness and blood pressure after long-term rosuvastatin treatment in patients with inflammatory joint diseases: results from the RORA-AS Study","volume":"11","author":"Ikdahl","year":"2016","journal-title":"PLoS One"},{"key":"2021031104123908400_keaa190-B16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.39114","article-title":"Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: the rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021031104123908400_keaa190-B17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-015-0795-y","article-title":"Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study","volume":"17","author":"Ikdahl","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021031104123908400_keaa190-B18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.HYP.0000255790.98391.9b","article-title":"Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension","volume":"49","author":"Schillaci","year":"2007","journal-title":"Hypertension"},{"key":"2021031104123908400_keaa190-B19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2021031104123908400_keaa190-B20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/ard.2010.149260","article-title":"Association with joint damage and physical functioning of nine composite indices and the 2011 ACR\/EULAR remission criteria in rheumatoid arthritis","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021031104123908400_keaa190-B21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2021031104123908400_keaa190-B22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2017.12.086","article-title":"Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network)","volume":"258","author":"Gerdts","year":"2018","journal-title":"Int J Cardiol"},{"key":"2021031104123908400_keaa190-B23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/HJH.0000000000000922","article-title":"Impact and pitfalls of scaling of left ventricular and atrial structure in population-based studies","volume":"34","author":"Kuznetsova","year":"2016","journal-title":"J Hypertens"},{"key":"2021031104123908400_keaa190-B24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/art.37949","article-title":"Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study","volume":"65","author":"Myasoedova","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021031104123908400_keaa190-B25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2017.03.108","article-title":"Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population","volume":"240","author":"Davis","year":"2017","journal-title":"Int J Cardiol"},{"key":"2021031104123908400_keaa190-B26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3899\/jrheum.171124","article-title":"Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy","volume":"45","author":"Midtb\u00f8","year":"2018","journal-title":"J Rheumatol"},{"key":"2021031104123908400_keaa190-B27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/annrheumdis-2012-201489","article-title":"Etanercept normalises left ventricular mass in patients with rheumatoid arthritis","volume":"72","author":"Da\u00efen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021031104123908400_keaa190-B28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"2021031104123908400_keaa190-B29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am J Hypertens"},{"key":"2021031104123908400_keaa190-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2019.03.059","article-title":"Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study)","volume":"286","author":"Eskerud","year":"2019","journal-title":"Int J Cardiol"},{"key":"2021031104123908400_keaa190-B31","doi-asserted-by":"crossref","first-page":"e000981","DOI":"10.1136\/openhrt-2018-000981","article-title":"Impact of aortic stiffness on myocardial ischaemia in non-obstructive coronary artery disease","volume":"6","author":"L\u00f8nnebakken","year":"2019","journal-title":"Open Heart"},{"key":"2021031104123908400_keaa190-B32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2021031104123908400_keaa190-B33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"2021031104123908400_keaa190-B34","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2016-209176","article-title":"Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy","volume":"75","author":"van der Valk","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021031104123908400_keaa190-B35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"Maki-Petaja","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2021031104123908400_keaa190-B36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2017.10.013","article-title":"The anti-inflammatory effects of statins on patients with rheumatoid arthritis: a systemic review and meta-analysis of 15 randomized controlled trials","volume":"17","author":"Li","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021031104123908400_keaa190-B37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2125.2010.03745.x","article-title":"Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction","volume":"70","author":"Wallace","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"2021031104123908400_keaa190-B38","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2021031104123908400_keaa190-B39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ejechocard\/jer051","article-title":"Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes","volume":"12","author":"Galderisi","year":"2011","journal-title":"Eur J Echocardiogr"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/12\/3700\/36508253\/keaa190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/12\/3700\/36508253\/keaa190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T04:32:39Z","timestamp":1615437159000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/12\/3700\/5835363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,5,9]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa190","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,5,9]]}}}